Key players include President Trump and the White House (budget request), CMS (rule issuance), HHS (budget target), and Congress (appropriations process, already underway with House markups in mid-April and Senate in June).[1][4][8] The budget signals administration priorities like defense boosts and domestic cuts but is non-binding, often altered by bipartisan congressional resistance, as seen in prior rejections of HHS program eliminations.[1][4]
These events follow the IRA's Part D redesign and ongoing FY2027 appropriations kicked off by the late PBR (due February but released April).[1][2][8] The CMS rule provides regulatory certainty before MA/Part D bid deadlines, with updates to Star Ratings (removing 11 administrative measures, declining Health Equity Index), TPMO oversight, SSBCI guardrails, and risk adjustment using the 2024 model.[2][7][9][15]
Newsworthy amid FY2027 spending debates and MA/Part D stability for 65 million+ enrollees, as the budget's HHS cuts and CMS deregulatory shifts (e.g., reduced admin burdens, payment accuracy) shape health policy ahead of October 1, 2026, implementation despite uncertain congressional adoption.[1][2][13]